LIVN · LivaNova PLC · Webcasts, Transcripts & Audio
$75.07
+0.37 (+0.50%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$4.22B
Shares
55.09M
Volume · Oct 2
528.52K
Avg daily vol (3M)
648.21K
LivaNova PLC Webcasts
Earnings calls, investor updates, investor days and conferences for LivaNova PLC (LIVN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼3.9%
$254.15M
$16.44M
'22 Q2
22-08-03
▼0.2%
$252.60M
−$107.34M
'22 Q3
22-11-02
▲1.8%
$274.87M
$1.66M
'22 Q4
23-02-22
▲15.6%
$293.88M
$1.16M
'23 Q2
23-07-26
▲13.3%
$286.11M
−$7.32M
'23 Q3
23-11-01
▲12.8%
$310.13M
$16.34M
'23 Q4
24-02-21
▲12%
$294.91M
−$41.94M
'24 Q1
24-05-01
▲8.4%
$318.57M
$16.33M
'24 Q2
24-07-31
▲11.2%
$318.12M
$32.95M
'24 Q3
24-10-30
▲3.8%
$321.83M
$55.89M
'24 Q4
25-02-25
▲7.4%
$316.86M
−$327.32M
'25 Q1
25-05-07
▲10.7%
$352.52M
$27.16M
'25 Q2
25-09-10
▲12.5%
$357.75M
$26.78M
'25 Q3
25-11-05
▲12.1%
$360.92M
$30.91M
'25 Q4
26-02-25
▲14.3%
$362.26M
$22.29M
'26 Q1
26-05-06
LATEST
▲10.8%
$390.59M
$108.57M
'26 Q2
26-08-05
Earnings call
FY26 · Q2
2026-08-05
LivaNova PLC (LIVN) Q2 2026 Earnings Call Transcript
Confident tone
Epilepsy segment and VNS growth
Cardiopulmonary segment performance
Innovation pipeline including OSA / LSA
Revenue
$390.59M
▲ 10.8% YoY Diluted EPS
$1.93
▲ 286% YoY Gross margin
70.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-06-10
LivaNova PLC (LIVN) June 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-08
LivaNova PLC (LIVN) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-06
LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript
Confident tone
Epilepsy / VNS commercial execution and reimbursement
Cardiopulmonary growth and Essenz
OSA / aura6000 and pHGNS opportunity
Revenue
$362.26M
▲ 14.3% YoY Diluted EPS
$0.40
Gross margin
67.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
LivaNova PLC (LIVN) Q4 2025 Earnings Call Transcript
Confident tone
Epilepsy business and VNS Therapy
Cardiopulmonary segment growth
Reimbursement improvements
Revenue
$360.92M*
▲ 12.1% YoY Gross margin
66.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
LivaNova PLC (LIVN) Q3 2025 Earnings Call Transcript
Confident tone
Cardiopulmonary Growth and Essenz Launch
Epilepsy and CORE-VNS Clinical Evidence
Investor Day and Strategic Framework
Revenue
$357.75M
▲ 12.5% YoY Diluted EPS
$0.49
▼ 18.3% YoY Gross margin
68.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-09-10
LivaNova PLC (LIVN) Q2 2025 Earnings Call Transcript
Confident tone
China Market Launch
Epilepsy / VNS Franchise
Cardiopulmonary Growth & Essenz Rollout
Revenue
$352.52M
▲ 10.7% YoY Diluted EPS
$0.50
▲ 66.7% YoY Gross margin
67.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
LivaNova PLC (LIVN) Q1 2025 Earnings Call Transcript
Positive tone
2025 Financial Guidance
Cardiopulmonary Segment and Essenz Rollout
Epilepsy Segment and SenTiva Field Safety Notice
Revenue
$316.86M
▲ 7.4% YoY Diluted EPS
$-6.01
Gross margin
68.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
LivaNova PLC (LIVN) Q4 2024 Earnings Call
Revenue
$321.83M*
▲ 3.8% YoY Gross margin
66.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-30
LivaNova PLC (LIVN) Q3 2024 Earnings Call Transcript
Confident tone
Epilepsy Business
Revenue Growth and Market Share
Reimbursement and Coding
Revenue
$318.12M
▲ 11.2% YoY Diluted EPS
$0.60
Gross margin
69.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
LivaNova PLC (LIVN) Q2 2024 Earnings Call Transcript
Positive tone
Cardiopulmonary growth and Essenz ramp
Innovation and R&D leadership
Epilepsy franchise performance
Revenue
$318.57M
▲ 8.4% YoY Diluted EPS
$0.30
▲ 1400% YoY Gross margin
67.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
LivaNova PLC (LIVN) Q1 2024 Earnings Call Transcript
Positive tone
New CEO priorities and leadership transition
Cardiopulmonary segment and Essenz launch
RECOVER difficult-to-treat depression study
Revenue
$294.91M
▲ 12% YoY Diluted EPS
$-0.78
▼ 657.1% YoY Gross margin
68.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
LivaNova PLC (LIVN) Q4 2023 Earnings Call Transcript
Positive tone
Cardiopulmonary growth and Essenz
CEO transition
ACS wind down
Revenue
$310.13M*
▲ 12.8% YoY Gross margin
56.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
LivaNova PLC (LIVN) Q3 2023 Earnings Call Transcript
Revenue
$286.11M
▲ 13.3% YoY Diluted EPS
$-0.14
Gross margin
70.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
LivaNova PLC (LIVN) Q2 2023 Earnings Call Transcript
Revenue
$293.88M
▲ 15.6% YoY Diluted EPS
$0.02
▼ 93.3% YoY Gross margin
69.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
LivaNova PLC (LIVN) Q4 2022 Earnings Call Transcript
Revenue
$274.87M*
▲ 1.8% YoY Gross margin
66.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
LivaNova PLC (LIVN) Q3 2022 Earnings Call Transcript
Revenue
$252.60M
▼ 0.2% YoY Diluted EPS
$-2.01
Gross margin
67.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
LivaNova PLC (LIVN) Q2 2022 Earnings Call Transcript
Revenue
$254.15M
▼ 3.9% YoY Diluted EPS
$0.30
Gross margin
72.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
LivaNova PLC (LIVN) Q1 2022 Earnings Call Transcript
Revenue
$240.18M
▼ 3% YoY Diluted EPS
$0.06
Gross margin
70.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
LivaNova PLC (LIVN) Q4 2021 Earnings Call Transcript
Revenue
$270.06M
▲ 0.2% YoY Diluted EPS
$-0.10
Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
LivaNova PLC (LIVN) Q3 2021 Earnings Call Transcript
Revenue
$253.22M
▲ 5.5% YoY Diluted EPS
$-0.84
Gross margin
66.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
LivaNova PLC (LIVN) Q2 2021 Earnings Call Transcript
Revenue
$264.48M
▲ 45.2% YoY Diluted EPS
$-1.15
Gross margin
65.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-28
LivaNova PLC (LIVN) Q1 2021 Earnings Call Transcript
Revenue
$247.60M
▲ 2.1% YoY Diluted EPS
$-0.63
▼ 184% YoY Gross margin
66.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
LivaNova PLC (LIVN) Q4 2020 Earnings Call Transcript
Revenue
$269.56M
▼ 6.3% YoY Diluted EPS
$-5.78
Gross margin
61.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-29
LivaNova PLC (LIVN) Q3 2020 Earnings Call Transcript
Revenue
$240.08M
▼ 10.6% YoY Diluted EPS
$-0.30
▼ 145.5% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-29
LivaNova PLC (LIVN) Q2 2020 Earnings Call Transcript
Revenue
$182.21M
▼ 34.3% YoY Diluted EPS
$-1.84
Gross margin
63.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-29
LivaNova PLC (LIVN) Q1 2020 Earnings Call Transcript
Revenue
$242.40M
▼ 3.4% YoY Diluted EPS
$0.75
Gross margin
68.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-26
LivaNova PLC (LIVN) Q4 2019 Earnings Call
Revenue
$287.59M
▼ 3.2% YoY Diluted EPS
$-2.96
Gross margin
71.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 webcasts